BIO Share Price

Open 219.67 Change Price %
High 219.67 1 Day -3.72 -1.69
Low 215.29 1 Week -2.66 -1.21
Close 216.28 1 Month -15.09 -6.52
Volume 154618 1 Year 62.85 40.96
52 Week High 242.79
52 Week Low 147.68
BIO Important Levels
Resistance 2 220.34
Resistance 1 218.67
Pivot 217.08
Support 1 213.89
Support 2 212.22
NYSE USA Most Active Stocks
RAI 65.40 -2.23%
RAI 65.40 -2.23%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
SE 40.68 -0.78%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
WSH 47.18 -2.86%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
GLF 0.34 25.93%
GLF 0.34 25.93%
CVO 4.21 16.62%
FNP 35.24 12.02%
FNP 35.24 12.02%
ATLS 0.10 11.11%
DMD 6.35 9.48%
DMD 6.35 9.48%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Bio-Rad Laboratories, Inc. (NYSE: BIO)

BIO Technical Analysis 2
As on 15th Aug 2017 BIO Share Price closed @ 216.28 and we RECOMMEND Buy for LONG-TERM with Stoploss of 196.46 & Strong Sell for SHORT-TERM with Stoploss of 227.25 we also expect STOCK to react on Following IMPORTANT LEVELS.
BIO Target for August
1st Target up-side 243.91
2nd Target up-side 249.71
3rd Target up-side 255.51
1st Target down-side 227.35
2nd Target down-side 221.55
3rd Target down-side 215.75
BIO Other Details
Segment EQ
Market Capital 2921876992.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.bio-rad.com
BIO Address
BIO
1000 Alfred Nobel Drive
Hercules, CA 94547
United States
Phone: 510-724-7000
Fax: 510-741-5817
BIO Latest News
Interactive Technical Analysis Chart Bio-Rad Laboratories, Inc. ( BIO NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Bio-Rad Laboratories, Inc.
BIO Business Profile
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physiciansÂ’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.